Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

Semaglutide is a drug that’s available in several different products, including Ozempic and Wegovy, both injectable medications. It belongs to the drug class known as glucagon-like peptide-1 ...

So, what did the study find and what does this all mean ... It’s easy to look at the data and think semaglutide causes a rare ...

Let's take a closer look ... mg weekly. Common side effects include nausea, vomiting, diarrhea, and constipation. Consult your healthcare provider or the Ozempic medication guide for more information.

A new clinical trial suggests that once-weekly semaglutide may reduce alcohol consumption and cravings in adults with alcohol use disorder.

Semaglutide 7.2 mg had a safety profile consistent with other GLP-1 receptor agonists, according to the press release. The most common adverse events were gastrointestinal and were mild or ...

The 40-week SUSTAIN 7 trial investigated the efficacy and safety of 0.5 mg semaglutide compared with 0.75 dulaglutide and 1.0 mg semaglutide compared with 1.5 mg dulaglutide, when added to metformin.